Vaccinex : ASCO Conference Presentation - MarketScreener
Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate PEPINEMAB IN COMBINATION WITH PEMBROLIZUMAB for first-linetreatment...
Source: marketscreener.com
Antigen Presentation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Antigen Presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Antigen Presentation Today - Breaking & Trending Today
Biognosys Presenting Data on its TrueDiscovery and TrueTarget Proteomics Platforms at the AACR Annual Meeting 2022
Data from Biognosys and its collaborators demonstrate the technological advances and utility of their proteomics platforms in oncology R&D and clinical settings Biognosys, a leader in next-generation
Source: finanznachrichten.de
Frontiers | Emergence of Dengue 4 as Dominant Serotype During 2017 Outbreak in South India and Associated Cytokine Expression Profile
Dengue virus infection is prevalent in tropical and sub-tropical regions of the world, which is fatal if untreated symptomatically. Emergence of new genotype within serotypes led to enhanced severity. The objective of the study is to identify the molecular characteristics of the DENV circulated during 2017 outbreak in Tamil Nadu, India and, to investigate the role of inflammatory cytokines in different ‘serotypes’ and in ‘dengue severity’. A total of 135 suspected samples were tested for DENV infection using IgM, IgG and qPCR assay; where 76 samples were positive for DENV and analysed ...
Source: frontiersin.org
Portage Biotech Highlights Safety and Survival Data from Intensity Therapeutics' IT-01 Study of INT230-6 (PORT-1) at ASCO 2021 Annual Meeting
- Data from the IT-01 trial demonstrate the safety of INT230-6 (PORT-1) as both a monotherapy and in combination with checkpoint inhibitors in solid tumors - Survival data looks favorable compared to similar historical populations, balanced for prognostic factorsWestport, Connecticut--(Newsfile Corp. - June 2, 2021) - Portage Biotech Inc., (NASDAQ: PRTG) ("Portage" or the "Company") a ...
Source: yahoo.com